{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T12:05:46Z","timestamp":1770552346494,"version":"3.49.0"},"reference-count":109,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T00:00:00Z","timestamp":1708387200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,5,21]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Currently, four vaccines for COVID-19 have been licensed by the European Medicines Agency: two viral vector-based vaccines and two mRNA-based vaccines. Since their approval, several cutaneous reactions related to vaccination have been reported in the literature. Among these, viral reactivations are one of the most frequent. The aim of this article was to investigate the current literature regarding viral reactivations following COVID-19 vaccination, focusing attention on pityriasis rosea (PR), herpes zoster and herpes simplex. A comprehensive literature search using various databases was performed and we included metanalyses, reviews, letters to the editor, real-life studies, case series and reports. A total of 48 articles involving 2067 patients were selected. Of these, 32, 6 and 17 articles reported varicella zoster virus (VZV) reactivation (1758 patients), herpes simplex virus (HSV) (238 patients) onset and PR (71 patients), respectively (some articles discussed more than one of these three reactivations). Possible pathogenetic mechanisms underlying viral reactivation are still not understood. Also, the possible correlations between vaccination and viral reactivation should be clarified. Certainly, vaccination should not be discouraged.<\/jats:p>","DOI":"10.1093\/ced\/llae061","type":"journal-article","created":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T07:54:25Z","timestamp":1708415665000},"page":"556-565","source":"Crossref","is-referenced-by-count":3,"title":["Viral reactivation following COVID-19 vaccination: a\u00a0review of the current literature"],"prefix":"10.1093","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2523-050X","authenticated-orcid":false,"given":"Fabrizio","family":"Martora","sequence":"first","affiliation":[{"name":"Department of Clinical Medicine and Surgery, Section of Dermatology, University of Naples Federico II , Napoli , Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matteo","family":"Megna","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine and Surgery, Section of Dermatology, University of Naples Federico II , Napoli , Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1136-637X","authenticated-orcid":false,"given":"Teresa","family":"Battista","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine and Surgery, Section of Dermatology, University of Naples Federico II , Napoli , Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimiliano","family":"Scalvenzi","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine and Surgery, Section of Dermatology, University of Naples Federico II , Napoli , Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6430-268X","authenticated-orcid":false,"given":"Alessia","family":"Villani","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine and Surgery, Section of Dermatology, University of Naples Federico II , Napoli , Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Cacciapuoti","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine and Surgery, Section of Dermatology, University of Naples Federico II , Napoli , Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5940-0592","authenticated-orcid":false,"given":"Luca","family":"Potestio","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine and Surgery, Section of Dermatology, University of Naples Federico II , Napoli , Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,2,20]]},"reference":[{"key":"2024052116315219000_llae061-B1","doi-asserted-by":"crossref","first-page":"202","DOI":"10.3390\/v13020202","article-title":"COVID-19: a review on the novel coronavirus disease evolution, transmission, detection, control and prevention","volume":"13","author":"Sharma","year":"2021","journal-title":"Viruses"},{"key":"2024052116315219000_llae061-B2","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/978-3-030-85113-2_2","article-title":"Outbreak of COVID-19: a detailed overview and its consequences","author":"Shivalkar","year":"2021","journal-title":"Adv Exp Med Biol"},{"key":"2024052116315219000_llae061-B3","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11061511","article-title":"Teledermatology and inflammatory skin conditions during COVID-19 era: new perspectives and applications","volume":"11","author":"Marasca","year":"2022","journal-title":"J Clin Med"},{"key":"2024052116315219000_llae061-B4","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.2147\/CCID.S377029","article-title":"The role of teledermatology during the COVID-19 pandemic: a narrative review","volume":"15","author":"Ruggiero","year":"2022","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"2024052116315219000_llae061-B5","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.2147\/CCID.S388245","article-title":"Cutaneous reactions following COVID-19 vaccination: a review of the current literature","volume":"15","author":"Martora","year":"2022","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"2024052116315219000_llae061-B6","author":"European Medicines Agency"},{"key":"2024052116315219000_llae061-B7","doi-asserted-by":"crossref","first-page":"714170","DOI":"10.3389\/fimmu.2021.714170","article-title":"Efficacy, immunogenicity and safety of COVID-19 vaccines: a systematic review and meta-analysis","volume":"12","author":"Sharif","year":"2021","journal-title":"Front Immunol"},{"key":"2024052116315219000_llae061-B8","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1111\/jocd.14938","article-title":"Teledermatology: a useful tool also after COVID-19 era?","volume":"21","author":"Megna","year":"2022","journal-title":"J Cosmet Dermatol"},{"key":"2024052116315219000_llae061-B9","doi-asserted-by":"crossref","first-page":"e237","DOI":"10.1111\/ijd.16236","article-title":"Impact of the COVID-19 pandemic on hospital admissions of patients with rare diseases: an experience of a Southern Italy referral center","volume":"61","author":"Martora","year":"2022","journal-title":"Int J Dermatol"},{"key":"2024052116315219000_llae061-B10","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/1346-8138.16651","article-title":"Cutaneous manifestations of COVID-19 and COVID-19 vaccination","volume":"50","author":"Nakashima","year":"2023","journal-title":"J Dermatol"},{"key":"2024052116315219000_llae061-B11","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/jocd.15414","article-title":"COVID-19 vaccination and inflammatory skin diseases","volume":"22","author":"Martora","year":"2023","journal-title":"J Cosmet Dermatol"},{"key":"2024052116315219000_llae061-B12","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.3906\/sag-2005-182","article-title":"COVID-19 and dermatology","volume":"50","author":"G\u00fcl","year":"2020","journal-title":"Turkish J Med Sci"},{"key":"2024052116315219000_llae061-B13","doi-asserted-by":"crossref","DOI":"10.3390\/v15071423","article-title":"The impact of COVID-19 vaccination on inflammatory skin disorders and other cutaneous diseases: a review of the published literature","volume":"15","author":"Martora","year":"2023","journal-title":"Viruses"},{"key":"2024052116315219000_llae061-B14","author":"Johns Hopkins Coronavirus Resource Centre"},{"key":"2024052116315219000_llae061-B15","doi-asserted-by":"crossref","first-page":"192","DOI":"10.3390\/v14020192","article-title":"Herpes zoster: a review of clinical manifestations and management","volume":"14","author":"Patil","year":"2022","journal-title":"Viruses"},{"key":"2024052116315219000_llae061-B16","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.mcna.2013.02.002","article-title":"Herpes zoster","volume":"97","author":"O\u2019Connor","year":"2013","journal-title":"Med Clin North Am"},{"key":"2024052116315219000_llae061-B17","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/jmv.25304","article-title":"Acute pain and postherpetic neuralgia related to varicella zoster virus reactivation: comparison between typical herpes zoster and zoster sine herpete","volume":"91","author":"Drago","year":"2019","journal-title":"J Med Virol"},{"key":"2024052116315219000_llae061-B18","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1177\/09564624211055298","article-title":"Clinical presentation of herpes simplex virus infection mimicking neoplasia on the face of persons living with HIV","volume":"33","author":"Edwards","year":"2022","journal-title":"Int J STD AIDS"},{"key":"2024052116315219000_llae061-B19","doi-asserted-by":"crossref","first-page":"e15225","DOI":"10.1111\/dth.15225","article-title":"Pityriasis rosea after moderna mRNA-1273 vaccine: a case series","volume":"35","author":"Martora","year":"2022","journal-title":"Dermatol Ther"},{"key":"2024052116315219000_llae061-B20","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1002\/jmv.27535","article-title":"Can COVID-19 cause atypical forms of pityriasis rosea refractory to conventional therapies?","volume":"94","author":"Martora","year":"2022","journal-title":"J\u00a0Med Virol"},{"key":"2024052116315219000_llae061-B21","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1002\/jmv.27672","article-title":"Pityriasis rosea during COVID-19: pathogenesis, diagnosis and treatment","volume":"94","author":"Ciccarese","year":"2022","journal-title":"J Med Virol"},{"key":"2024052116315219000_llae061-B22","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.clindermatol.2022.01.002","article-title":"Pityriasis rosea, pityriasis rosea-like eruptions, and herpes zoster in the setting of COVID-19 and COVID-19 vaccination","volume":"40","author":"Drago","year":"2022","journal-title":"Clin Dermatol"},{"key":"2024052116315219000_llae061-B23","first-page":"e38772","article-title":"A review of pityriasis rosea in relation to SARS-CoV-2\/COVID-19 infection and vaccination","volume":"15","author":"Wong","year":"2023","journal-title":"Cureus"},{"key":"2024052116315219000_llae061-B24","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.jdcr.2018.04.002","article-title":"Pityriasis rosea and pityriasis rosea-like eruptions: how to distinguish them?","volume":"4","author":"Drago","year":"2018","journal-title":"JAAD Case Rep"},{"key":"2024052116315219000_llae061-B25","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1159\/000445375","article-title":"Pityriasis rosea: a comprehensive classification","volume":"232","author":"Drago","year":"2016","journal-title":"Dermatology"},{"key":"2024052116315219000_llae061-B26","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jdin.2022.03.018","article-title":"Pityriasis rosea and pityriasis rosea-like eruptions after COVID-19 vaccines","volume":"9","author":"Drago","year":"2022","journal-title":"JAAD Int"},{"key":"2024052116315219000_llae061-B27","doi-asserted-by":"crossref","first-page":"467","DOI":"10.7326\/M18-0850","article-title":"PRISMA Extension for Scoping Reviews (PRISMA-ScR): checklist and explanation","volume":"169","author":"Tricco","year":"2018","journal-title":"Ann Intern Med"},{"key":"2024052116315219000_llae061-B28","doi-asserted-by":"crossref","first-page":"777","DOI":"10.7326\/M14-2385","article-title":"The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations","volume":"162","author":"Hutton","year":"2015","journal-title":"Ann Intern Med"},{"key":"2024052116315219000_llae061-B29","doi-asserted-by":"crossref","first-page":"b2700","DOI":"10.1136\/bmj.b2700","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration","volume":"339","author":"Liberati","year":"2009","journal-title":"BMJ"},{"key":"2024052116315219000_llae061-B30","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.jaad.2021.11.025","article-title":"Risk of herpes zoster reactivation after messenger RNA COVID-19 vaccination: a cohort study","volume":"87","author":"Birabaharan","year":"2022","journal-title":"J Am Acad Dermatol"},{"key":"2024052116315219000_llae061-B31","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1056\/NEJMoa2110475","article-title":"Safety of the BNT162b2 mRNA Covid-19 vaccine in a nationwide setting","volume":"385","author":"Barda","year":"2021","journal-title":"N Engl J Med"},{"key":"2024052116315219000_llae061-B32","doi-asserted-by":"crossref","first-page":"572","DOI":"10.3390\/vaccines9060572","article-title":"Reactivation of varicella zoster virus after vaccination for SARS-CoV-2","volume":"9","author":"Psichogiou","year":"2021","journal-title":"Vaccines"},{"key":"2024052116315219000_llae061-B33","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1136\/annrheumdis-2021-220647","article-title":"Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general population: a multicentre study","volume":"80","author":"Furer","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"2024052116315219000_llae061-B34","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jdcr.2021.04.014","article-title":"Varicella-zoster virus reactivation after SARS-CoV-2 BNT162b2 mRNA vaccination: report of 5 cases","volume":"12","author":"Rodr\u00edguez-Jim\u00e9nez","year":"2021","journal-title":"JAAD Case Rep"},{"key":"2024052116315219000_llae061-B35","doi-asserted-by":"crossref","first-page":"e750","DOI":"10.1111\/jdv.17555","article-title":"Herpes zoster following SARS-CoV-2 vaccination \u2013 a series of four cases","volume":"35","author":"Alpalh\u00e3o","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2024052116315219000_llae061-B36","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1093\/qjmed\/hcab208","article-title":"Herpes zoster following COVID-19 vaccine: a report of three cases","volume":"114","author":"Chiu","year":"2021","journal-title":"QJM"},{"key":"2024052116315219000_llae061-B37","doi-asserted-by":"crossref","first-page":"445","DOI":"10.25259\/IJDVL_819_2021","article-title":"Disseminated and localised herpes zoster following Oxford-AstraZeneca COVID-19 vaccination","volume":"88","author":"Jiang","year":"2022","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"2024052116315219000_llae061-B38","doi-asserted-by":"crossref","first-page":"101359","DOI":"10.1016\/j.ajoc.2022.101359","article-title":"Covid-19 vaccination and possible link to herpes zoster","volume":"25","author":"Lazzaro","year":"2022","journal-title":"Am J Ophthalmol Case Rep"},{"key":"2024052116315219000_llae061-B39","doi-asserted-by":"crossref","first-page":"3384","DOI":"10.1111\/jocd.14437","article-title":"Recurrent herpes zoster after COVID-19 vaccination in patients with chronic urticaria being treated with cyclosporine \u2013 a report of 3 cases","volume":"20","author":"Mohta","year":"2021","journal-title":"J Cosmet Dermatol"},{"key":"2024052116315219000_llae061-B40","doi-asserted-by":"crossref","first-page":"e845","DOI":"10.1111\/jdv.17576","article-title":"Herpes zoster after ChAdOx1 nCoV-19 vaccine: a case series","volume":"35","author":"Vastarella","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2024052116315219000_llae061-B41","doi-asserted-by":"crossref","first-page":"e846","DOI":"10.1111\/jdv.17577","article-title":"Herpes zoster after inactivated SARS-CoV-2 vaccine in two healthy young adults","volume":"35","author":"\u00d6zdemir","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2024052116315219000_llae061-B42","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ajo.2023.07.004","article-title":"Risk of herpes zoster ophthalmicus after COVID-19 vaccination in a large US healthcare claims database","volume":"258","author":"Akpandak","year":"2024","journal-title":"Am J Ophthalmol"},{"key":"2024052116315219000_llae061-B43","doi-asserted-by":"crossref","first-page":"3376","DOI":"10.1111\/jocd.14470","article-title":"Herpes zoster after COVID-19 vaccination \u2013 can the vaccine reactivate latent zoster virus?","volume":"20","author":"Palanivel","year":"2021","journal-title":"J Cosmet Dermatol"},{"key":"2024052116315219000_llae061-B44","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/ICO.0000000000002881","article-title":"Herpes zoster ophthalmicus after COVID-19 vaccination: chance occurrence or more?","volume":"41","author":"Rehman","year":"2022","journal-title":"Cornea"},{"key":"2024052116315219000_llae061-B45","first-page":"e18418","article-title":"Herpes zoster following COVID-19 vaccination in long-term breast cancer survivors","volume":"13","author":"Toscani","year":"2021","journal-title":"Cureus"},{"key":"2024052116315219000_llae061-B46","doi-asserted-by":"crossref","first-page":"198","DOI":"10.7774\/cevr.2021.10.2.198","article-title":"A rare case of shingles after COVID-19 vaccine: is it a possible adverse effect?","volume":"10","author":"Aksu","year":"2021","journal-title":"Clin Exp Vaccine Res"},{"key":"2024052116315219000_llae061-B47","doi-asserted-by":"crossref","first-page":"e04883","DOI":"10.1002\/ccr3.4883","article-title":"Herpes-like skin lesion after AstraZeneca vaccination for COVID-19: a case report","volume":"9","author":"Ardalan","year":"2021","journal-title":"Clin Case Rep"},{"key":"2024052116315219000_llae061-B48","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jdcr.2021.05.042","article-title":"Herpes zoster reactivation after mRNA-1273 (Moderna) SARS-CoV-2 vaccination","volume":"15","author":"Channa","year":"2021","journal-title":"JAAD Case Rep"},{"key":"2024052116315219000_llae061-B49","doi-asserted-by":"crossref","first-page":"898","DOI":"10.36849\/JDD.6146","article-title":"Herpes zoster following COVID-19 vaccination","volume":"20","author":"David","year":"2021","journal-title":"J Drugs Dermatol"},{"key":"2024052116315219000_llae061-B50","doi-asserted-by":"crossref","first-page":"e620","DOI":"10.1111\/jdv.17422","article-title":"Ipsilateral herpes zoster after the first dose of BNT162b2 mRNA COVID-19 vaccine","volume":"35","author":"Tessas","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2024052116315219000_llae061-B51","doi-asserted-by":"crossref","first-page":"e15707","DOI":"10.1111\/dth.15707","article-title":"Postherpetic granulomatous dermatitis and herpes zoster necroticans triggered by Covid-19 vaccination","volume":"35","author":"Tripathy","year":"2022","journal-title":"Dermatol Ther"},{"key":"2024052116315219000_llae061-B52","doi-asserted-by":"crossref","first-page":"100171","DOI":"10.1016\/j.metop.2022.100171","article-title":"Herpes zoster following COVID-19 vaccination in an immunocompetent and vaccinated for herpes zoster adult: a two-vaccine related event?","volume":"13","author":"Vallianou","year":"2022","journal-title":"Metab Open"},{"key":"2024052116315219000_llae061-B53","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/bjd.20639","article-title":"Cutaneous reactions after SARS-CoV-2 vaccination: a cross-sectional Spanish nationwide study of 405 cases","volume":"186","author":"Catal\u00e0","year":"2022","journal-title":"Br J Dermatol"},{"key":"2024052116315219000_llae061-B54","doi-asserted-by":"crossref","first-page":"e165","DOI":"10.3346\/jkms.2022.37.e165","article-title":"A case report of herpes zoster ophthalmicus and meningitis after COVID-19 vaccination","volume":"37","author":"You","year":"2022","journal-title":"J Korean Med Sci"},{"key":"2024052116315219000_llae061-B55","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1111\/jdv.17646","article-title":"Varicella-zoster and herpes simplex virus reactivation post-COVID-19 vaccination: a review of 40 cases in an International Dermatology Registry","volume":"36","author":"Fathy","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2024052116315219000_llae061-B56","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/ijd.16116","article-title":"Herpes zoster reactivation after COVID-19 vaccination \u2013 a retrospective case series of 22 patients","volume":"61","author":"Naoum","year":"2022","journal-title":"Int J Dermatol"},{"key":"2024052116315219000_llae061-B57","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1111\/jocd.14210","article-title":"20 Post-COVID-19 vaccine-related shingles cases seen at the Las Vegas Dermatology clinic and sent to us via social media","volume":"20","author":"Lee","year":"2021","journal-title":"J Cosmet Dermatol"},{"key":"2024052116315219000_llae061-B58","doi-asserted-by":"crossref","first-page":"57","DOI":"10.17085\/apm.22207","article-title":"Herpes zoster after COVID-19 vaccination, aspect of pain medicine: a retrospective, single-center study","volume":"18","author":"Lee","year":"2023","journal-title":"Anesth Pain Med"},{"key":"2024052116315219000_llae061-B59","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jaad.2021.03.092","article-title":"Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: a registry-based study of 414 cases","volume":"85","author":"McMahon","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"2024052116315219000_llae061-B60","first-page":"284","article-title":"Herpes zoster after mRNA COVID-19 vaccination: a case series","volume":"20","author":"Monastirli","year":"2022","journal-title":"Skinmed"},{"key":"2024052116315219000_llae061-B61","doi-asserted-by":"crossref","first-page":"245792","DOI":"10.1136\/bcr-2021-245792","article-title":"Reactivation of herpes simplex keratitis following vaccination for COVID-19","volume":"14","author":"Richardson-May","year":"2021","journal-title":"BMJ Case Rep"},{"key":"2024052116315219000_llae061-B62","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1080\/09273948.2022.2055580","article-title":"Herpes simplex virus 1 anterior uveitis following coronavirus disease 2019 (COVID-19) vaccination in an Asian Indian female","volume":"30","author":"Sangoram","year":"2022","journal-title":"Ocul Immunol Inflamm"},{"key":"2024052116315219000_llae061-B63","first-page":"431","article-title":"Pityriasis rosea as a possible complication of vaccination against COVID-19","volume":"118","author":"Dormann","year":"2021","journal-title":"Dtsch Arztebl Int"},{"key":"2024052116315219000_llae061-B64","doi-asserted-by":"crossref","first-page":"752443","DOI":"10.3389\/fmed.2021.752443","article-title":"Case report: pityriasis rosea-like eruption following COVID-19 vaccination","volume":"8","author":"Leerunyakul","year":"2021","journal-title":"Front Med"},{"key":"2024052116315219000_llae061-B65","doi-asserted-by":"crossref","first-page":"e721","DOI":"10.1111\/jdv.17498","article-title":"Pityriasis rosea developing after COVID-19 vaccination","volume":"35","author":"Marcantonio-Santa Cruz","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2024052116315219000_llae061-B66","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.1111\/jdv.17678","article-title":"Erythema nodosum, zoster duplex and pityriasis rosea as possible cutaneous adverse effects of Oxford-AstraZeneca COVID-19 vaccine: report of three cases from India","volume":"36","author":"Mehta","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2024052116315219000_llae061-B67","doi-asserted-by":"crossref","first-page":"e15129","DOI":"10.1111\/dth.15129","article-title":"Pityriasis rosea-like cutaneous eruption as a possible dermatological manifestation after Oxford-AstraZeneca vaccine: case report and brief literature review","volume":"34","author":"Pedrazini","year":"2021","journal-title":"Dermatol Ther"},{"key":"2024052116315219000_llae061-B68","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ijid.2021.10.055","article-title":"Pityriasis rosea shortly after mRNA-1273 COVID-19 vaccination","volume":"114","author":"Shin","year":"2022","journal-title":"Int J Infect Dis"},{"key":"2024052116315219000_llae061-B69","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.jfma.2021.12.028","article-title":"Pityriasis rosea-like eruptions following COVID-19 mRNA-1273 vaccination: a case report and literature review","volume":"121","author":"Wang","year":"2022","journal-title":"J Formos Med Assoc"},{"key":"2024052116315219000_llae061-B70","doi-asserted-by":"crossref","first-page":"3080","DOI":"10.1111\/jocd.14372","article-title":"Pityriasis rosea following SARS-CoV-2 vaccination: a case series","volume":"20","author":"Temiz","year":"2021","journal-title":"J Cosmet Dermatol"},{"key":"2024052116315219000_llae061-B71","doi-asserted-by":"crossref","first-page":"e489","DOI":"10.1111\/jdv.17301","article-title":"Pityriasis rosea, COVID-19 and vaccination: new keys to understand an old acquaintance","volume":"35","author":"Busto-Leis","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2024052116315219000_llae061-B72","doi-asserted-by":"crossref","first-page":"e546","DOI":"10.1111\/jdv.17342","article-title":"Pityriasis rosea-like eruptions following vaccination with BNT162b2 mRNA COVID-19 Vaccine","volume":"35","author":"Cyrenne","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2024052116315219000_llae061-B73","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1111\/ijd.15700","article-title":"Pityriasis rosea after mRNA COVID-19 vaccination","volume":"60","author":"Abdullah","year":"2021","journal-title":"Int J Dermatol"},{"key":"2024052116315219000_llae061-B74","doi-asserted-by":"crossref","first-page":"e15040","DOI":"10.1111\/dth.15040","article-title":"Post Covid-19 vaccination papulovesicular pityriasis rosea-like eruption in a young male","volume":"34","author":"Adya","year":"2021","journal-title":"Dermatol Ther"},{"key":"2024052116315219000_llae061-B75","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1002\/jmv.27364","article-title":"Atypical pityriasis rosea associated with mRNA COVID-19 vaccine","volume":"94","author":"Bostan","year":"2022","journal-title":"J Med Virol"},{"key":"2024052116315219000_llae061-B76","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1111\/bjd.20143","article-title":"Pityriasis rosea-like eruption after Pfizer-BioNTech COVID-19 vaccination","volume":"185","author":"Carballido V\u00e1zquez","year":"2021","journal-title":"Br J Dermatol"},{"key":"2024052116315219000_llae061-B77","doi-asserted-by":"crossref","first-page":"4097","DOI":"10.1080\/21645515.2021.1963173","article-title":"Pityriasis rosea after administration of Pfizer-BioNTech COVID-19 vaccine","volume":"17","author":"Cohen","year":"2021","journal-title":"Hum Vaccin Immunother"},{"key":"2024052116315219000_llae061-B78","first-page":"11","article-title":"Zoster sine herpete and COVID vaccine","volume":"70","author":"Bhandary","year":"2022","journal-title":"J Assoc Physicians India"},{"key":"2024052116315219000_llae061-B79","doi-asserted-by":"crossref","first-page":"e01563","DOI":"10.1016\/j.idcr.2022.e01563","article-title":"Zoster sine herpete following BNT162b2 mRNA COVID-19 vaccination in an immunocompetent patient","volume":"29","author":"Tanizaki","year":"2022","journal-title":"IDCases"},{"key":"2024052116315219000_llae061-B80","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1111\/ijd.15809","article-title":"Scabies outbreak during COVID-19: an Italian experience","volume":"60","author":"De Lucia","year":"2021","journal-title":"Int J Dermatol"},{"key":"2024052116315219000_llae061-B81","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1056\/NEJMoa2118691","article-title":"Protection against SARS-CoV-2 after Covid-19 vaccination and previous infection","volume":"386","author":"Hall","year":"2022","journal-title":"N Engl J Med"},{"key":"2024052116315219000_llae061-B82","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1007\/s10900-021-00984-3","article-title":"The nature and extent of COVID-19 vaccination hesitancy in healthcare workers","volume":"46","author":"Biswas","year":"2021","journal-title":"J Community Health"},{"key":"2024052116315219000_llae061-B83","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1111\/jdv.18531","article-title":"Skin reaction after SARS-CoV-2 vaccines Reply to \u2018cutaneous adverse reactions following SARS-CoV-2 vaccine booster dose: a real-life multicentre experience\u2019","volume":"37","author":"Martora","year":"2023","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2024052116315219000_llae061-B84","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s10354-021-00876-0","article-title":"\u00a0Cutaneous and hypersensitivity reactions associated with COVID-19 vaccination \u2013 a narrative review","volume":"172","author":"Wollina","year":"2022","journal-title":"Wien Med Wochenschr"},{"key":"2024052116315219000_llae061-B85","doi-asserted-by":"crossref","first-page":"e15197","DOI":"10.1111\/dth.15197","article-title":"\u2018Covid arm\u2019: abnormal side effect after Moderna COVID-19 vaccine","volume":"35","author":"Picone","year":"2022","journal-title":"Dermatol Ther"},{"key":"2024052116315219000_llae061-B86","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s13555-022-00689-y","article-title":"A case of new-onset lichen planus after COVID-19 vaccination","volume":"12","author":"Picone","year":"2022","journal-title":"Dermatol Ther (Heidelb)"},{"key":"2024052116315219000_llae061-B87","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1093\/infdis\/jit252","article-title":"Reactivation of herpes simplex virus type 2 after initiation of antiretroviral therapy","volume":"208","author":"Tobian","year":"2013","journal-title":"J Infect Dis"},{"key":"2024052116315219000_llae061-B88","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1742-6405-4-9","article-title":"Immune reconstitution inflammatory syndrome (IRIS): review of common infectious manifestations and treatment options","volume":"4","author":"Murdoch","year":"2007","journal-title":"AIDS Res Ther"},{"key":"2024052116315219000_llae061-B89","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1159\/000356176","article-title":"Pityriasis rosea in a hepatitis B-positive patient treated with pegylated interferon \u03b12a: report of a case and review of the literature","volume":"228","author":"Drago","year":"2014","journal-title":"Dermatology"},{"key":"2024052116315219000_llae061-B90","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1080\/14760584.2022.2044799","article-title":"Herpes zoster and simplex reactivation following COVID-19 vaccination: new insights from a vaccine adverse event reporting system (VAERS) database analysis","volume":"21","author":"Gringeri","year":"2022","journal-title":"Expert Rev Vaccines"},{"key":"2024052116315219000_llae061-B91","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1080\/14760584.2022.2036128","article-title":"Association of COVID-19 vaccination with herpes zoster: a systematic review and meta-analysis","volume":"21","author":"Chu","year":"2022","journal-title":"Expert Rev Vaccines"},{"key":"2024052116315219000_llae061-B92","doi-asserted-by":"crossref","first-page":"e13730","DOI":"10.1111\/dth.13730","article-title":"The clinics of HHV-6 infection in COVID-19 pandemic: pityriasis rosea and Kawasaki disease","volume":"33","author":"Dursun","year":"2020","journal-title":"Dermatol Ther"},{"key":"2024052116315219000_llae061-B93","article-title":"Similarity between cutaneous reactions due to SARS-CoV-2 and its vaccinations","volume":"10","author":"Kutlu","year":"2022","journal-title":"Future Virol"},{"key":"2024052116315219000_llae061-B94","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1111\/ced.15395","article-title":"Immune response to COVID-19 mRNA vaccination in patients with psoriasis undergoing treatment with biologics","volume":"47","author":"Megna","year":"2022","journal-title":"Clin Exp Dermatol"},{"key":"2024052116315219000_llae061-B95","doi-asserted-by":"crossref","first-page":"2198050","DOI":"10.1080\/09546634.2023.2198050","article-title":"New-onset and flares of psoriasis after COVID-19 infection or vaccination successfully treated with biologics: a case series","volume":"34","author":"Gargiulo","year":"2023","journal-title":"J Dermatolog Treat"},{"key":"2024052116315219000_llae061-B96","doi-asserted-by":"crossref","first-page":"5339","DOI":"10.1111\/jocd.15331","article-title":"Cutaneous \u00adreactions following booster dose of COVID-19 mRNA vaccination: what we should know?","volume":"21","author":"Potestio","year":"2022","journal-title":"J Cosmet Dermatol"},{"key":"2024052116315219000_llae061-B97","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/jocd.15533","article-title":"Cutaneous reactions following COVID-19 vaccination: the evidence says \u2018less fear\u2019","volume":"22","author":"Potestio","year":"2023","journal-title":"J Cosmet Dermatol"},{"key":"2024052116315219000_llae061-B98","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1111\/ced.15336","article-title":"The impact of COVID-19 infection on patients with psoriasis treated with biologics: an Italian experience","volume":"47","author":"Ruggiero","year":"2022","journal-title":"Clin Exp Dermatol"},{"key":"2024052116315219000_llae061-B99","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jdcr.2022.03.008","article-title":"Hidradenitis suppurativa flares following COVID-19 vaccination: a case series","volume":"23","author":"Martora","year":"2022","journal-title":"JAAD Case Rep"},{"key":"2024052116315219000_llae061-B100","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/ca.23790","article-title":"A narrative review and clinical anatomy of herpes zoster infection following COVID-19 vaccination","volume":"35","author":"Iwanaga","year":"2022","journal-title":"Clin Anat"},{"key":"2024052116315219000_llae061-B101","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/iid3.568","article-title":"Cutaneous reactions to COVID-19 vaccine at the dermatology primary care","volume":"10","author":"Burlando","year":"2022","journal-title":"Immun Inflamm Dis"},{"key":"2024052116315219000_llae061-B102","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1111\/ced.15306","article-title":"Management of patients with hidradenitis suppurativa during COVID-19 vaccination: an\u00a0experience from southern Italy. Comment on: \u2018Evaluating the safety and efficacy of COVID-19 vaccination in patients with\u00a0hidradenitis suppurativa\u2019","volume":"47","author":"Martora","year":"2022","journal-title":"Clin Exp Dermatol"},{"key":"2024052116315219000_llae061-B103","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1111\/ced.15291","article-title":"Strategies adopted in a southern Italian referral centre to reduce adalimumab discontinuation: comment on \u2018Can we increase the drug survival time of biologic therapies in hidradenitis suppurativa?\u2019","volume":"47","author":"Martora","year":"2022","journal-title":"Clin Exp Dermatol"},{"key":"2024052116315219000_llae061-B104","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/jocd.15477","article-title":"COVID-19 and cutaneous manifestations: a review of the published literature","volume":"22","author":"Martora","year":"2023","journal-title":"J Cosmet Dermatol"},{"key":"2024052116315219000_llae061-B105","doi-asserted-by":"crossref","first-page":"e750","DOI":"10.1111\/jdv.18302","article-title":"Reply to \u2018Development of severe pemphigus vulgaris following SARS-CoV-2 vaccination with BNT162b2\u2019 by Solimani et\u00a0al.","volume":"36","author":"Martora","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2024052116315219000_llae061-B106","doi-asserted-by":"crossref","first-page":"e649","DOI":"10.1111\/jdv.17480","article-title":"Development of severe pemphigus vulgaris following SARS-CoV-2 vaccination with BNT162b2","volume":"35","author":"Solimani","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2024052116315219000_llae061-B107","doi-asserted-by":"crossref","first-page":"e804","DOI":"10.1002\/iid3.804","article-title":"Manifestation of pityriasis rosea and pityriasis rosea-like eruptions after Covid-19 vaccine: a systematic review","volume":"11","author":"Khan","year":"2023","journal-title":"Immun Inflamm Dis"},{"key":"2024052116315219000_llae061-B108","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1080\/13543784.2023.2219387","article-title":"The holistic approach to psoriasis patients with comorbidities: the role of investigational drugs","volume":"32","author":"Camela","year":"2023","journal-title":"Expert Opin Investig Drugs"},{"key":"2024052116315219000_llae061-B109","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1159\/000521712","article-title":"A case of pemphigus vulgaris and hidradenitis suppurativa: may systemic steroids be considered in the standard management of hidradenitis suppurativa?","volume":"8","author":"Martora","year":"2022","journal-title":"Skin Appendage disord"}],"container-title":["Clinical and Experimental Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ced\/advance-article-pdf\/doi\/10.1093\/ced\/llae061\/57163102\/llae061.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/article-pdf\/49\/6\/556\/57800728\/llae061.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/article-pdf\/49\/6\/556\/57800728\/llae061.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T16:32:59Z","timestamp":1716309179000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ced\/article\/49\/6\/556\/7610958"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,20]]},"references-count":109,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,2,20]]},"published-print":{"date-parts":[[2024,5,21]]}},"URL":"https:\/\/doi.org\/10.1093\/ced\/llae061","relation":{},"ISSN":["0307-6938","1365-2230"],"issn-type":[{"value":"0307-6938","type":"print"},{"value":"1365-2230","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,6]]},"published":{"date-parts":[[2024,2,20]]}}}